Oncolytics Biotech Inc. (ONCY) is a Calgary-based clinical-stage biopharmaceutical company focused on pioneering oncolytic virus therapies for cancer treatment. Its leading candidate, pelareorep, uniquely targets cancer cells while enhancing the body’s immune response against tumors. With a robust pipeline and ongoing clinical trials, Oncolytics aims to deliver innovative solutions for patients with a range of cancers. The company leverages strategic collaborations and a strong research background, positioning itself as a key player in the evolving oncology market.